FEATURE: FDA Updates Extended Use Drugs List to Meet COVID-19 Demands

FEATURE


FDA Updates Extended Use Drugs List to Meet COVID-19 Demands

Protocols ASCs need to put in place to use these medications safely and avoid citations

BY SAHELY MUKERJI | JUNE-JULY 2020

In light of the COVID-19 pandemic and the consequent demand for certain medications, the US Food & Drug Administration (FDA) updated its list of extended-use drugs on April 3. The updated list now includes 569 drugs that may be used beyond the manufacturer’s labeled expiration date.

To read this article, you have to be a member of ASCA or subscribe to ASC Focus magazine.

Sign in > Join >Subscribe >